top of page
09:00 - 09:45
13 June
P2
Healing the mental health crisis: The emerging potential of psychedelics
With 1 in 4 people experiencing mental health issues worldwide, we ask this incredible panel of health and tech luminaries, can we solve the mental health crisis with psychedelics?
Catherine Bird
Clinical Trials Manager - Psychedelic Trials Group, King's College London
Christian Angermayer
Co-founder & Chairman - Apeiron Investment Group
Dr Ekaterina Malievskaia
Chief Innovations Office - COMPASS Pathways
.png)
Michael Stothard
Principal - firstminute capital
Festival Stage 1
bottom of page